体外循环中肝素涂层管道应用的进展

er LK, Garcia E, Turina M. Perfusion without systemic h eparinization for rewarming in accidental hypothermia［J］. Ann Thorac Surg , 1991, 52:560-561. ［23］Saito A, Hayashi J, Eguchi S. Mechanical circulatory assist using heparin-coated tube and roller pump system［J］. Ann Thorac Surg , 19 92, 53: 659-665. ［24］Fjalldal O, Torfason PT, et al. Prolonged total extracorporeal lu ng assistance without systemic heparinization［J］. Acta Anaesthesiol Scand, 1993,37:115-120. ［25］Hayashi Y, Ohtake S, Sawa Y, et al. Percutaneous cardiopulmonary support with heparin-coated circuits in postcardiotomy cardiogenic shoc k. Efficacy and comparison with left heart bypass［J］. Jpn J Thorac Ca rdiovasc Surg 2000 May;48(5):274-279. ［26］Edmunds LH. Surface-bound heparin:panacea or peril ［J］Ann Thora c Surg 1994,58:285-286. ［27］Cheung AT, Levin SK, Weiss SJ, et al. Intracardiac thrombus: a ri sk of incomplete anticoagulation for cardiac operations［J］. Ann Thora c Surg 1994,58:541-542. ［28］Muehrcke D, McCarthy PM, Marchant KK, et al. Biocompatibility of heparin-coated extracorporeal bypass circuits:a randomized,masked clini cal trial［J］. J Thorac Cardiovasc Surg 1996,112:472-483. ［29］Schreurs HH, Wijers MJ, Gu YJ, et al. Heparin-coated bypass circu it: effects on inflammatory response in pediatric cardiac operations［J ］. Ann Torac Surg 1998,66:166-171. ［30］Ashraf S, Tian Y. Release of proinflammatory cytokines during ped iatric CPB:heparin-bonded vursus nonbonded oxygenetors［J］. Ann Thora c Surg 1997,64:1790-1794. ［31］Edmunds LH, Jr. Breaking the blood-biomaterial balance［J］. ASA IO J 1995，41:824-830. ［32］qvrum E, Holen EA, Tangen G, et al. Heparinized CPB and full sys tem heparin dose marginally improve clinical performance［J］. Ann Thor ac Surg 1996,62:1128-1133. ［33］Baufreton C, Le Besnerais P, Janson P, et al. Clinical outcome af ter coronary surgery with heparin-coated extracorporeal circuits［J］. Perfusion 1996,11:437-443. ［34］Olsson C, Siegbahn A, Henze A, et al. Heparin-coated cardiopulmon ary bypass circuits reduce circulating complement factors and interleuk in-6 in paediatric heart surgery. Scand Cardiovasc J 2000,34(1):33-40. ［35］Mullen JC, Bentley MJ, Gelfand ET. Coronary artery bypass surgery with heparin-coated perfusion circuits and low-dose heparinization［J］ . Can J Surg 2002 Jun;45(3):166-172. ［36］Tayama E, Hayashida N, Akasu K, et al. Biocompatibility of hepari n-coated extracorporeal bypass circuits: new heparin bonded bioline sys tem［J］. Artif Organs 2000 Aug;24(8):618-623. ［37］Van der Linden J, Jinder D, Thelin S, et al. Heprin-coated cardio pulmonary circuits protect against impaired cognitive function three mo nths after coronary artery bypass grafting［J］. Perfusion, 1993, 8: 25 0. ［38］Ranuci M, Cirri S, ContiD et al. Beneficial effects of Duraflo II heparin-coated circuits on postperfusion lung dysfunction［J］. Ann T orac Surg 1996,61:76-81. ［39］Steinberg JB, Kapelanski DP, Olson JD, et al. Cytokine and comple ment levels in pat

《体外循环中肝素涂层管道应用的进展(第4页)》